Neil Sawhney

1.3k total citations · 1 hit paper
12 papers, 981 citations indexed

About

Neil Sawhney is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Neil Sawhney has authored 12 papers receiving a total of 981 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 8 papers in Surgery and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Neil Sawhney's work include Cardiac Valve Diseases and Treatments (6 papers), Coronary Interventions and Diagnostics (6 papers) and Acute Myocardial Infarction Research (4 papers). Neil Sawhney is often cited by papers focused on Cardiac Valve Diseases and Treatments (6 papers), Coronary Interventions and Diagnostics (6 papers) and Acute Myocardial Infarction Research (4 papers). Neil Sawhney collaborates with scholars based in United States, Australia and South Korea. Neil Sawhney's co-authors include Paul S. Teirstein, Matthew J. Price, Richard A. Schatz, Raghava Gollapudi, Curtiss Stinis, Sarah Endemann, Justin Levisay, Jeffrey W. Moses, Martin B. Leon and John Kao and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Neil Sawhney

12 papers receiving 952 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation

2008 498 citations Matthew J. Price, Sarah Endemann et al. European Heart Journal profile →

Peers

Countries citing papers authored by Neil Sawhney

Since Specialization

Citations

This map shows the geographic impact of Neil Sawhney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil Sawhney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil Sawhney more than expected).

Fields of papers citing papers by Neil Sawhney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil Sawhney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil Sawhney. The network helps show where Neil Sawhney may publish in the future.

Co-authorship network of co-authors of Neil Sawhney

This figure shows the co-authorship network connecting the top 25 collaborators of Neil Sawhney. A scholar is included among the top collaborators of Neil Sawhney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil Sawhney. Neil Sawhney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation breakdown → 2008 ·European Heart Journal ·Matthew J. Price, Sarah Endemann, Raghava Gollapudi, (unknown), Curtiss Stinis, Justin Levisay, (unknown), Neil Sawhney, Richard A. Schatz, Paul S. Teirstein	498
2	Efficacy and Safety of Triple Antiplatelet Therapy With and Without Concomitant Anticoagulation During Elective Percutaneous Coronary Intervention (the REMOVE Trial) 2007 ·The American Journal of Cardiology ·(unknown), Matthew J. Price, Neil Sawhney, (unknown), Garrett B. Wong, Raghava Gollapudi, (unknown), Richard A. Schatz, Paul S. Teirstein	9
3	Early- and Medium-Term Outcomes After Paclitaxel-Eluting Stent Implantation for Sirolimus-Eluting Stent Failure 2006 ·The American Journal of Cardiology ·(unknown), Matthew J. Price, Garrett B. Wong, (unknown), (unknown), Neil Sawhney, Raghava Gollapudi, Richard A. Schatz, Paul S. Teirstein	26
4	Serial Angiographic Follow-Up of Sirolimus-Eluting Stents for Unprotected Left Main Coronary Artery Revascularization 2006 ·Journal of the American College of Cardiology ·Matthew J. Price, Ecaterina Cristea, Neil Sawhney, John Kao, Jeffrey W. Moses, Martin B. Leon, Ricardo A. Costa, Alexandra J. Lansky, Paul S. Teirstein	143
5	Differential Effects Between Intravenous and Targeted Renal Delivery of Fenoldopam on Renal Function and Blood Pressure in Patients Undergoing Cardiac Catheterization 2006 ·The American Journal of Cardiology ·Paul S. Teirstein, Matthew J. Price, Vandana Mathur, Hooman Madyoon, Neil Sawhney, Donald S. Baim	32
6	Recent Trends in the Percutaneous Treatment of Chronic Total Coronary Occlusions 2006 ·The American Journal of Cardiology ·J. Dawn Abbott, Kevin E. Kip, Helen Vlachos, Neil Sawhney, (unknown), Alice K. Jacobs, David R. Holmes, David O. Williams	56
7	Direct thrombin inhibition appears to be a safe and effective anticoagulant for percutaneous bypass graft interventions 2006 ·Catheterization and Cardiovascular Interventions ·John Kao, A. Michael Lincoff, Eric J. Topol, (unknown), Matthew J. Price, Neil Sawhney, Paul S. Teirstein	3
8	Clinical outcomes after sirolimus‐eluting stent implantation for de novo saphenous vein graft lesions 2005 ·Catheterization and Cardiovascular Interventions ·Matthew J. Price, Neil Sawhney, John Kao, (unknown), Richard A. Schatz, Paul S. Teirstein	25
9	Treatment of Left Anterior Descending Coronary Artery Disease With Sirolimus-Eluting Stents 2004 ·Circulation ·Neil Sawhney, Jeffrey W. Moses, Martin B. Leon, Richard E. Kuntz, Jeffrey J. Popma, William Bachinsky, Theodore A. Bass, Samuel J. DeMaio, Edward T.A. Fry, David R. Holmes, Paul S. Teirstein	68
10	Calcific Aortic Stenosis in the Elderly: A Brief Overview 2003 ·The American Journal of Geriatric Cardiology ·Neil Sawhney, Alborz Hassankhani, Barry Greenberg	2
11	Common femoral artery anatomy is influenced by demographics and comorbidity: Implications for cardiac and peripheral invasive studies 2001 ·Catheterization and Cardiovascular Interventions ·Guido Schnyder, Neil Sawhney, Brian Whisenant, Sotirios Tsimikas, Zoltan G. Turi	91
12	Electrophysiologic Effects of the New Class III Antiarrhythmic Drug Dofetilide Compared to the Class IA Antiarrhythmic Drug Quinidine in Experimental Canine Atrial Flutter: 1996 ·Journal of Cardiovascular Electrophysiology ·(unknown), (unknown), Steven E. Wolf, (unknown), Neil Sawhney, Gregory K. Feld	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact